Babcock & Wilcox Enterprises Inc buy krebskrebs
Start price
28.04.20
/
50%
€0.86
Target price
04.11.21
€0.90
Performance (%)
666.08%
End price
05.11.21
€6.55
Summary
This prediction ended on 05.11.21 with a price of €6.55. The BUY prediction by krebskrebs for Babcock & Wilcox Enterprises Inc saw massive gains of 666.08%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Babcock & Wilcox Enterprises Inc | -9.043% | -9.043% | 514.683% | 68.370% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % | 64,71 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % | 88,24 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % | 79,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % | 69,60 % |
Comments by krebskrebs for this prediction
In the thread Babcock & Wilcox Enterprises Inc diskutieren
Buy mit Kursziel 0,9
In the thread Trading Babcock & Wilcox Enterprises Inc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

